Skip to main content

Table 1 Clinical characteristics of patients

From: Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

Characteristic

Number

Performance status

 0

168 (48%)

 1

168 (48%)

 2

15 (4%)

Primary location

 right breast

168 (48%)

 left breast

183 (52%)

Age (years)

 31–40

26 (7%)

 41–50

63 (18%)

 51–60

70 (20%)

 61–70

91 (26%)

 71–80

91 (26%)

 81–90

10 (3%)

Family history of neoplastic disease

 yes

53 (15%)

 no

298 (85%)

Place of residence

 city

232 (66%)

 rural area

119 (34%)

Smoking status

 yes

133 (38%)

 no

218 (62%)

Education

 lower than secondary

88 (25%)

 secondary

186 (53%)

 higher

77 (22%)

Disease dissemination

 primary

147 (42%)

 secondary

204 (58%)

Chemotherapy regimen

 chemotherapy

139 (40%)

 hormone therapy

121 (34%)

 anti-HER2 therapy

91 (26%)